Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-06-21

FDA Approved: PULMICORT FLEXHALER — Supplemental Application (H2-Pharma LLC)

View source ↗

Summary

FDA approved a supplemental application for PULMICORT FLEXHALER (budesonide) by H2-Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PULMICORT FLEXHALER (BUDESONIDE)

Snippet

SUPPL AP for PULMICORT FLEXHALER (BUDESONIDE)